|
Index of reports
> Cases with Neutropenia (89)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 89 Next >>
Possible Prednisone side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-23
Patient: female, weighing 81.8 kg (180.0 pounds)
Reactions: Dyspnoea, Chest Pain, Pancytopenia, Pyrexia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1400 mg
Doxorubicin Hydrochloride
Dosage: 94 mg
Prednisone
Dosage: 375 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 700 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Tachycardia, Clostridium Difficile Colitis, Pancytopenia, Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2780 mg
Doxorubicin Hydrochloride
Dosage: 152 mg
Etoposide
Dosage: 720 mg
Fluorine-18 2-Fluorou-2 Deoxyry-D-Glucose (18f-Fdg)
Dosage: 12 mg
Prednisone
Dosage: 1300 mg
Rituximab
Dosage: 800 mg
Vincristine Sulfate
Dosage: 3.6 mg
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 55.2 kg (121.4 pounds)
Reactions: Unresponsive To Stimuli, Moaning, Neutropenia, Septic Shock, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Start date: 2009-08-21
Methotrexate Sodium
Prednisone
Vincristine
End date: 2012-08-10
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient:
Reactions: Hospitalisation, Neuropathy Peripheral, Vomiting, Febrile Neutropenia, Neutropenia, Neutrophil Count Decreased, Lymphoma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: B-Cell Lymphoma
Rituximab
Indication: B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in 76 year old
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 76 year old
Reactions: Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: daily for 5 days
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in
Reported by a physician from United Kingdom on 2012-08-01
Patient:
Reactions: Neutropenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1440 mg, unk
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 96 mg, unk
Indication: Mantle Cell Lymphoma
Prednisone
Dosage: 100 mg, unk
Indication: Mantle Cell Lymphoma
Prednisone
Dosage: 80 unk, unk
Velcade
Dosage: 3 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2011-01-27
Vincristine
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sando K / 00031402 /
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01
Patient: male
Reactions: Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Mabthera
Indication: B-Cell Lymphoma
Prednisone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Prednisone side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Nausea, Motor Dysfunction, Pain, Rash, Peripheral Sensory Neuropathy, Fatigue, Dyspepsia, Blood Potassium Decreased, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Cyclophosphamide
Dosage: on day 1
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Cyclophosphamide
Dosage: on day 1
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Waldenstrom's Macroglobulinaemia
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphocytic Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: maintenance
Indication: Waldenstrom's Macroglobulinaemia
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Rituximab
Dosage: on day 1
Indication: B-Cell Lymphoma
Rituximab
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: non-Hodgkin's Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: B-Cell Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: Lymphocytic Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Waldenstrom's Macroglobulinaemia
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Waldenstrom's Macroglobulinaemia
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphocytic Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: B-Cell Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphoma
Other drugs received by patient: Diphenhydramine HCL; Acetaminophen; Ondansetron
Possible Prednisone side effects in 74 year old male
Reported by a physician from Mexico on 2012-08-01
Patient: 74 year old male, weighing 65.0 kg (143.0 pounds)
Reactions: Pulmonary Oedema, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer
Start date: 2012-04-04
End date: 2012-04-04
Prednisone
Administration route: Oral
Indication: Prostate Cancer
Start date: 2012-04-04
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-31
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Prednisone side effects in male
Reported by a physician from Canada on 2012-07-30
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Platelet Count Decreased, Neutropenia, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-04-16
End date: 2012-04-23
Abiraterone Acetate
Administration route: Oral
Start date: 2012-04-27
End date: 2012-04-29
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-04-02
Other drugs received by patient: Phosphate
Possible Prednisone side effects in female
Reported by a physician from United Kingdom on 2012-07-27
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Anaemia, Neutropenia, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Furosemide
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-26
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 50.6 kg (111.3 pounds)
Reactions: Nausea, Urinary Tract Infection, Cytomegalovirus Viraemia, Rhinorrhoea, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Indication: Prophylaxis
Mycophenolate Mofetil
Dosage: unk
Administration route: Oral
Start date: 2011-05-16
End date: 2011-06-04
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-24
End date: 2011-05-16
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-10-23
Prograf
Dosage: 4 mg am, 5 mg pm
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-12-09
End date: 2011-05-16
Prograf
Dosage: 2 mg, bid
Administration route: Oral
Start date: 2011-05-16
Other drugs received by patient: Losartan Potassium; Lasix
Possible Prednisone side effects in
Reported by a physician from United Kingdom on 2012-07-25
Patient:
Reactions: Neutropenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1440 mg, unk
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 96 mg, unk
Indication: Mantle Cell Lymphoma
Prednisone
Dosage: 80 unk, unk
Prednisone
Dosage: 100 mg, unk
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 3 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2011-01-27
Vincristine
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sando K / 00031402 /
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-24
Patient: female, weighing 51.4 kg (113.1 pounds)
Reactions: Nausea, Urinary Tract Infection, Rhinorrhoea, Cytomegalovirus Viraemia, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Indication: Prophylaxis
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
End date: 2011-05-16
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Start date: 2011-05-16
End date: 2011-06-04
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-08-24
End date: 2011-05-04
Prednisone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-10-23
Prograf
Dosage: 4 mg am, 5 mg pm
Administration route: Oral
End date: 2011-05-16
Prograf
Dosage: 2 mg, bid
Administration route: Oral
Start date: 2011-05-24
Prograf
Dosage: 4 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-12-09
Prograf
Dosage: unk
Administration route: Oral
Start date: 2011-05-16
Other drugs received by patient: Losartan Potassium; Lasix
Possible Prednisone side effects in
Reported by a physician from Italy on 2012-07-20
Patient:
Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 100 mg on days 1-5 for chop and r-chop
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 375 mg/m2 on day 1 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in
Reported by a physician from United Kingdom on 2012-07-19
Patient:
Reactions: Neutropenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1440 mg, unk
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: 96 mg, unk
Indication: Mantle Cell Lymphoma
Prednisone
Dosage: 100 mg, unk
Indication: Mantle Cell Lymphoma
Prednisone
Dosage: 80 unk, unk
Velcade
Dosage: 3 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2011-01-27
Vincristine
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sando K / 00031402 /
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-07-18
Patient: female, weighing 59.1 kg (130.0 pounds)
Reactions: Abdominal Pain, Dehydration, Pancytopenia, Pyrexia, Neutropenia, Asthenia, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1250 mg
Doxorubicin Hydrochloride
Dosage: 84 mg
Prednisone
Dosage: 200 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 620 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-18
Patient: male
Reactions: Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Doxorubicin HCL
Mabthera
Indication: B-Cell Lymphoma
Prednisone
Vincristine
Possible Prednisone side effects in 80 year old male
Reported by a physician from India on 2012-07-16
Patient: 80 year old male, weighing 55.9 kg (123.0 pounds)
Reactions: Sepsis, Hypoglycaemia, Neutropenia, Cardiogenic Shock, Septic Shock, Pneumonitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer Metastatic
Start date: 2011-09-08
End date: 2011-09-08
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Dexamethasone; Granisetron; Lactulose; Avil; Vitamins with Minerals; Filgrastim; Antiseptics; Ranitidine; Ultracet; Chlordiazepoxide Hydrochloride / Clidinium Bromide; Metoclopramide; Crocin; Domstal
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-13
Patient:
Reactions: Neuropathy Peripheral, Neutropenia, Infection, Infusion Related Reaction
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: 6-821 day cycles; n=28
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: 6-821 day cycles; n=28
Obinutuzumab
Indication: B-Cell Lymphoma
Prednisone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-07-06
Patient: male, weighing 62.0 kg (136.4 pounds)
Reactions: Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2177 mg
Doxorubicin Hydrochloride
Dosage: 29 mg
Etoposide
Dosage: 145 mg
Prednisone
Dosage: 101 mg
Rituximab (Moab C2b8 Anti CD 20, Chimeric)
Dosage: 630 mg
Vincristine Sulfate
Dosage: .65 mg
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05
Patient:
Reactions: Arrhythmia Supraventricular, Gastrointestinal Toxicity, Hypotension, Anaemia, Atrial Fibrillation, Cardiac Disorder, Disease Progression, Death, Neuropathy Peripheral, Cardiac Failure, Embolism, Sepsis, Atrioventricular Block, Neutropenia, Thrombocytopenia, Myocardial Infarction, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Start date: 2006-04-01
Bortezomib
Dosage: 1.3 milligram/sq. meter
Prednisone
Dosage: 60 milligram/sq. meter
Indication: Multiple Myeloma
Start date: 2006-04-01
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2006-04-01
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-05
Patient:
Reactions: Neurotoxicity, Cardiotoxicity, Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisone side effects in
Reported by a physician from United States on 2012-07-05
Patient:
Reactions: Nausea, Anaemia, Chills, Constipation, Fatigue, Neuropathy Peripheral, Alopecia, Adverse Event, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Indication: Chronic Lymphocytic Leukaemia
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Prednisone
Dosage: on days 1-5
Administration route: Oral
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: B-Cell Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Chronic Lymphocytic Leukaemia
Rituximab
Dosage: on day 1
Rituximab
Dosage: maintenance
Velcade
Dosage: on days 1 and 8
Velcade
Dosage: on days 1 and 8
Indication: Chronic Lymphocytic Leukaemia
Velcade
Dosage: on days 1 and 8
Indication: B-Cell Lymphoma
Possible Prednisone side effects in female
Reported by a physician from France on 2012-06-29
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Febrile Bone Marrow Aplasia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Start date: 2011-12-29
Doxorubicin Hydrochloride
Start date: 2011-12-29
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma
Mabthera
Start date: 2011-12-29
End date: 2011-12-29
Mabthera
Indication: Lymphoma
Neulasta
Indication: Chemotherapy
Start date: 2011-12-30
End date: 2011-12-30
Prednisone
Indication: non-Hodgkin's Lymphoma
Prednisone
Start date: 2011-12-29
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-12-29
Vincristine
Other drugs received by patient: Bisoprolol Fumarate
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-06-12
Patient: male, weighing 62.0 kg (136.4 pounds)
Reactions: White Blood Cell Count Decreased, Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2177 mg
Doxorubicin Hydrochloride
Dosage: 116 mg
Etoposide
Dosage: 581 mg
Prednisone
Dosage: 1008 mg
Rituximab (Moab C2b8 Andti Cd20, Chimeric)
Dosage: 630 mg
Vincristine Sulfate
Dosage: 2.69 mg
Possible Prednisone side effects in male
Reported by a physician from Spain on 2012-06-07
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-12
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-12
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-11
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-12
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-12
Possible Prednisone side effects in 74 year old male
Reported by a physician from Mexico on 2012-06-05
Patient: 74 year old male, weighing 65.0 kg (143.0 pounds)
Reactions: Pulmonary Oedema, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer
Start date: 2012-04-04
End date: 2012-04-04
Prednisone
Administration route: Oral
Indication: Prostate Cancer
Start date: 2012-04-04
Page 1 Next >>
|
